Sponsors

Company Profile

Logical Therapeutics Inc.

Inflammation
Metabolic
Drug Development

518 Dorchester Dr.
Mars, PA 16046
USA
www.logicaltherapeutics.com 		Incorporated in 2005
2 Employees 		Privately Held

This Year's Highlights

  • Completed Seed financing round in August, 2006 with PA Early Stage Ventures.
  • Company completed in-licensing of novel Naproxen Pro-drug platform in August, 2006. The lead compound has already completed Phase 1 and will launch a Phase 2a study in 2007.

Anticipated Highlights

  • The company is currently seeking Series A capitalization to move its lead molecule small molecule into Phase II, and to move its two pre-clinical peptide programs into man.
  • The company anticipates additional seed funding from Innovation Works and the PA Ben Franklin Technology Parnters, as well as the Pittsburgh Life Sciences Greenhouse.

Corporate Mission

Logical Therapeutics is an early stage biotechnology company developing therapeutic agents to treat medical conditions caused by poorly controlled inflammatory responses.